中基健康(000972) - 2022 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2022 reached ¥53,088,896.01, representing a significant increase of 1,153.93% compared to the same period last year[4] - Total operating revenue for Q3 2022 reached ¥154,169,869.57, a significant increase from ¥7,359,465.17 in the same period last year, representing a growth of approximately 1,973%[20] - The net profit attributable to shareholders was ¥2,608,309.73, while the net profit after deducting non-recurring gains and losses was ¥2,075,452.02, indicating a recovery from previous losses[4] - The net profit for Q3 2022 was -¥24,557,362.28, an improvement from -¥54,876,089.09 in Q3 2021, reflecting a reduction in losses of approximately 55%[22] - Cash received from sales and services amounted to ¥348,581,823.20, reflecting a 2,209.55% increase year-on-year[8] - Cash received from sales of goods and services in Q3 2022 was ¥348,581,823.20, compared to ¥15,093,064.71 in Q3 2021, showing a growth of approximately 2,200%[22] Assets and Liabilities - Total assets increased by 46.05% year-on-year, reaching ¥987,388,973.30, while equity attributable to shareholders decreased by 35.48% to ¥44,669,475.36[4] - Total liabilities as of the end of Q3 2022 amounted to ¥937,609,660.00, up from ¥601,705,050.46 at the end of the previous year, marking an increase of approximately 55.7%[21] - The total equity attributable to shareholders of the parent company was ¥44,669,475.36, down from ¥69,229,040.21 year-over-year, indicating a decline of about 35.4%[21] - Current assets amounted to 702,305,556.55 yuan, up from 358,575,010.18 yuan at the start of the year[17] - The company has a total of 285,083,416.75 yuan in non-current assets, down from 317,466,516.09 yuan[17] Cash Flow - The company reported a net cash flow from operating activities of ¥86,836,466.34, a decline of 133.29% year-to-date[4] - The net cash flow from operating activities for Q3 2022 was ¥86,836,466.34, a turnaround from -¥260,820,543.21 in the same quarter last year[22] - The net cash flow from investment activities was 1,272,359.83, compared to a net outflow of 1,226,995.12 in the previous period[23] - The total cash inflow from financing activities was 0.00, while the cash outflow was 19,355,129.50, resulting in a net cash flow of -19,355,129.50[23] - The cash and cash equivalents at the end of the period increased to 89,271,187.09, up from 50,547,571.13 in the previous period[23] - The cash flow from operating activities was not detailed in the provided data, indicating a focus on investment and financing activities[23] Operational Efficiency and Future Plans - The company plans to continue expanding its production capabilities and improving operational efficiency to enhance profitability in the upcoming quarters[4] - The company is in the process of a major asset restructuring, with ongoing audits and evaluations[14] - The company will issue progress announcements on the asset restructuring every 30 days until the shareholder meeting notification is sent out[14] Shareholder Information - Total number of common shareholders at the end of the reporting period is 27,241[10] - The largest shareholder, Xinjiang Production and Construction Corps Sixth Division State-owned Assets Management Co., holds 16.18% of shares, totaling 124,769,223 shares, with 59,621,900 shares pledged[10] Research and Development - Research and development expenses were reported at ¥62,190.89, indicating a focus on innovation despite previous financial challenges[8] - Research and development expenses for Q3 2022 were ¥62,190.89, compared to no expenses in the same period last year, indicating a commitment to innovation[21] Other Financial Metrics - The gross profit margin improved, with operating costs rising to ¥137,996,368.64, a 1,652.71% increase compared to the previous year, driven by higher sales volume[7] - The company recorded a significant increase in government subsidies, totaling ¥587,639.63 for the current period, up from previous amounts[6] - The company has seen a 220% increase in cash received from tax refunds, amounting to ¥13,913,435.65, due to favorable national policies[8] - The company reported a credit impairment loss of -¥16,939,866.23 in Q3 2022, worsening from -¥7,435,512.20 in Q3 2021, reflecting increased credit risk[21] Audit and Reporting - The company did not undergo an audit for the third quarter report[24] - The company’s board of directors issued the report on October 26, 2022, reflecting timely financial disclosures[25]